Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Heliyon
|
March 21, 2024
The oncogene MYBL2 promotes the malignant phenotype and suppresses apoptosis through hedgehog signaling pathway in clear cell renal cell carcinoma
Wenjie Yang, Hualin Chen, Lin Ma, et al.
American Journal of Translational Research
|
September 14, 2018
Radiofrequency ablation plus nucleotide analogous for hepatitis B virus-related hepatocellular carcinoma: a cost-effectiveness analysis
Baoxian Liu, Mengchao Wei, Furong Liu, et al.
Aging
|
December 31, 2022
A comprehensive analysis of the FOX family for predicting kidney renal clear cell carcinoma prognosis and the oncogenic role of FOXG1
Wenjie Yang, Hualin Chen, Lin Ma, et al.
BMC Cancer
|
April 7, 2018
Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis
Shuling Chen, Zhenwei Peng, Mengchao Wei, et al.
Iscience
|
September 4, 2023
SHOX2 promotes prostate cancer proliferation and metastasis through disruption of the Hippo-YAP pathway
Wenjie Yang, Hualin Chen, Lin Ma, et al.
BMC Cancer
|
November 14, 2018
Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model
Zongren Wang, Han Xiao, Guangyan Wei, et al.
European Radiology
|
March 15, 2018
Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study
Zhenwei Peng, Mengchao Wei, Shuling Chen, et al.
Biomolecules & Biomedicine
|
November 3, 2022
Machine learning to improve prognosis prediction of metastatic clear-cell renal cell carcinoma treated with cytoreductive nephrectomy and systemic therapy
Wenjie Yang, Lin Ma, Jie Dong, et al.
Cancer Management and Research
|
August 3, 2019
TBH score: a new model to predict and prevent severe liver damage after chemotherapy for cancer patients
Mengping Zhang, Yong Bao, Wei Chen, et al.
Radiology
|
February 2, 2018
Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation
Zhenwei Peng, Shuling Chen, Mengchao Wei, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Heliyon
|
March 21, 2024
The oncogene MYBL2 promotes the malignant phenotype and suppresses apoptosis through hedgehog signaling pathway in clear cell renal cell carcinoma
Wenjie Yang, Hualin Chen, Lin Ma, et al.
American Journal of Translational Research
|
September 14, 2018
Radiofrequency ablation plus nucleotide analogous for hepatitis B virus-related hepatocellular carcinoma: a cost-effectiveness analysis
Baoxian Liu, Mengchao Wei, Furong Liu, et al.
Aging
|
December 31, 2022
A comprehensive analysis of the FOX family for predicting kidney renal clear cell carcinoma prognosis and the oncogenic role of FOXG1
Wenjie Yang, Hualin Chen, Lin Ma, et al.
BMC Cancer
|
April 7, 2018
Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis
Shuling Chen, Zhenwei Peng, Mengchao Wei, et al.
Iscience
|
September 4, 2023
SHOX2 promotes prostate cancer proliferation and metastasis through disruption of the Hippo-YAP pathway
Wenjie Yang, Hualin Chen, Lin Ma, et al.
BMC Cancer
|
November 14, 2018
Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model
Zongren Wang, Han Xiao, Guangyan Wei, et al.
European Radiology
|
March 15, 2018
Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study
Zhenwei Peng, Mengchao Wei, Shuling Chen, et al.
Biomolecules & Biomedicine
|
November 3, 2022
Machine learning to improve prognosis prediction of metastatic clear-cell renal cell carcinoma treated with cytoreductive nephrectomy and systemic therapy
Wenjie Yang, Lin Ma, Jie Dong, et al.
Cancer Management and Research
|
August 3, 2019
TBH score: a new model to predict and prevent severe liver damage after chemotherapy for cancer patients
Mengping Zhang, Yong Bao, Wei Chen, et al.
Radiology
|
February 2, 2018
Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation
Zhenwei Peng, Shuling Chen, Mengchao Wei, et al.
Page
of 3